ARGENICA THERAPEUTICS - Profile, contacts and insights

ARGENICA THERAPEUTICS

Who is ARGENICA THERAPEUTICS?

Argenica Therapeutics(ASX: AGN) is developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. Stroke is the leading cause of death and disability worldwide and the economic costs of treatment a...See more

Industry & Specialities

Pharmaceuticals

Manufacturing

Countries of Operation

Australia

Headquarters:

Australia

Company Type:

SME

Company size:

1-10 Employees

Year Founded:

2019 (7 years)

Address:

NEDLANDS, PERTH, WESTERN AUSTRALIA 6009, AU

The largest company and people database for SEA & ANZ

Employees by Department

IT / Product (1)
The Rest (6)
Total (7)

Key Decision Makers

Emma Waldon

CFO & Company Secretary

Meghan Thomas

Head of Clinical Development

Paul Bailey

Clinical Advisory Committee

Liz Dallimore

CEO & Managing Director

Insight

Signals

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Employees by Seniority

C-level

2employees

Senior

0employees

Non-managers

3employees

Financials

LOW

spending power

Funding Status

Private

Associated Legal Entities

0 entities

Ready to get started?

Start benefiting from our free-to-use platform today

Discover More Companies

Lookalike companies

Similar industry

Featured Lists

Fast Growing SMEs
Companies with Recent Funding > 100K
Companies with High Spending Power
MNCs / Large Enterprises in Singapore

Frequently Asked Questions (FAQ)

How long has ARGENICA THERAPEUTICS been operating for?
What is the funding status of ARGENICA THERAPEUTICS?
Where is ARGENICA THERAPEUTICS's headquarter?
What ARGENICA THERAPEUTICS's spending power?
Does ARGENICA THERAPEUTICS have a presence in the domain it operates in?